Clomiphene is a selective oestrogen receptor modulator (SERM) that induces gonadotrophin release by blocking hypothalamic oestrogen negative feedback, used as a first-line oral treatment for anovulatory infertility. Simson Pharma's Clomiphene reference standard and impurities support compendial testing for this widely used fertility agent.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Clomiphene Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.